From the Guidelines
The most effective approach to terminate seizures in the pre-hospital setting is the rapid administration of benzodiazepines, with midazolam being the preferred first-line agent for status epilepticus, but in cases where benzodiazepines are not effective, IV valproate is a highly effective alternative, as shown in a study by Misra et al 1. In the pre-hospital setting, the primary goal is to rapidly terminate seizures and prevent further brain damage.
- Benzodiazepines, such as midazolam, lorazepam, or diazepam, are the first-line treatment for status epilepticus due to their rapid onset of action and efficacy in terminating seizures.
- However, in cases where benzodiazepines are not effective, or when a second-line agent is needed, IV valproate has been shown to be at least as effective as phenytoin in controlling seizures, with potentially fewer adverse effects, as demonstrated in a study by Agarwal et al 1.
- The recommended dose of valproate is 20-30 mg/kg, infused at a rate of 6 mg/kg per hour, followed by a maintenance infusion of 1-2 mg/kg per hour, as shown in a Class III study 1.
- It is essential to note that valproate appears to be safe and effective in refractory status epilepticus and was not associated with hypotension, making it a viable alternative to phenytoin, as demonstrated in a study by Gilad et al 1.
- In addition to valproate, other second-line agents, such as levetiracetam or phenobarbital, may also be considered, as recommended by the Neurocritical Care Society’s Status Epilepticus Guideline Writing Committee 1.
- Ultimately, the choice of medication and dosage should be individualized based on the patient's specific needs and medical history, and emergency medical services should be contacted immediately for status epilepticus, as these patients often require additional medications and airway management.
From the FDA Drug Label
For the treatment of status epilepticus, the usual recommended dose of lorazepam injection is 4 mg given slowly (2 mg/min) for patients 18 years and older. If seizures cease, no additional lorazepam injection is required. If seizures continue or recur after a 10- to 15-minute observation period, an additional 4 mg intravenous dose may be slowly administered
- Lorazepam is the drug of choice for terminating seizures pre-hospital and for status epilepticus.
- The recommended dose is 4 mg given slowly (2 mg/min) for patients 18 years and older.
- A second dose of 4 mg may be administered if seizures continue or recur after a 10- to 15-minute observation period 2.
From the Research
Most Effective Treatment to Terminate Seizures Pre-Hospital
- The most effective treatment to terminate seizures pre-hospital is the administration of benzodiazepines, such as midazolam, intramuscularly, buccally, or nasally 3.
- Midazolam is effective and safe in the pre-hospital or home setting, and its use can prevent emergency room visits, improve quality of life, and lower healthcare costs 3.
- Other benzodiazepines, such as lorazepam and diazepam, may also be effective in terminating seizures pre-hospital 4, 5.
Drug Choice for Status Epilepticus
- Benzodiazepines, such as lorazepam, diazepam, and midazolam, are considered first-line therapy for status epilepticus 4, 5, 6, 7.
- After treatment with benzodiazepines, treatment with fosphenytoin, phenobarbital, valproate, and levetiracetam may be recommended 5, 7.
- The choice of drug for status epilepticus depends on the individual patient characteristics, and individualized therapy should be chosen based on these characteristics 7.
- For refractory status epilepticus, continuous intravenous infusions of anesthetic medications, such as midazolam, propofol, pentobarbital, and ketamine, may be utilized 7.
Key Considerations
- Rapid administration of adequate doses of anti-epileptic drugs is crucial in the management of status epilepticus 3.
- The exact choice of anti-epileptic drug is less important than rapid treatment and early consideration of reversible etiologies 3.
- Status epilepticus should be treated aggressively and quickly, with confirmation of treatment success with epileptiform electroencephalographic (EEG) 3.